SciELO Analytics (Beta)
Brasil
Memórias do Instituto Oswaldo Cruz (0074-0276)
Some aspects of treatment, prophylaxis and chemoresistance of plasmodium falciparum malaria

Received Citations (8)

publishing year previous first author document title
1997 Revista da Sociedade Brasileira de Medicina Tropical Boulos, Marcos Avaliação clínica do quinino para o tratamento de malária por Plasmodium falciparum
2001 Revista do Instituto de Medicina Tropical de São Paulo MENEZES, Carla M. S. Avaliação da sensibilidade in vitro à quinidina em isolados brasileiros de Plasmodium falciparum: análise comparativa à quinina e à cloroquina
1999 Memórias do Instituto Oswaldo Cruz Cerutti Junior, Crispim Antimalarial drug susceptibility testing of Plasmodium falciparum in Brazil using a radioisotope method
1991 Revista do Instituto de Medicina Tropical de São Paulo Neifer, S. Susceptibilidade a droga, do Plasmodium falciparum, na Amazônia Ocidental, Estado do Acre, Brasil
1988 Revista do Instituto de Medicina Tropical de São Paulo Di Santi, S.M. Evaluation of Plasmodium falciparum response to chloroquine, quinine and mefloquine
2011 Memórias do Instituto Oswaldo Cruz Gama, Bianca Ervatti Chemoresistance of Plasmodium falciparum and Plasmodium vivax parasites in Brazil: consequences on disease morbidity and control
1997 Revista do Instituto de Medicina Tropical de São Paulo SEGURADO, Aluisio Augusto Cotrim In vivo and in vitro Plasmodium falciparum Resistance to Chloroquine, Amodiaquine and Quinine in the Brazilian Amazon
2005 Revista Brasileira de Hematologia e Hemoterapia Torres, Felipe R. Human hemoglobins: malaria hypothesis or maternal effect?
This tool is under development and it is available in Beta Test version
This tool is under development and it was published with the objective to test the usage and performance. All the indicators are real and they are gradually being loaded. Slowness and out of service problems may occur in this version.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.